Author

J. Beimdiek

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:flow cytometry· 1 Research Focus:host-pathogen & immune response· 1 Assay:metabolomics· 1

Frequent Co-Authors

C. Rossdam· 3 shared F. F. R. Buettner· 3 shared A. Oberbeck· 2 shared A. Muenster-Kuehnel· 1 shared A. Tiede· 1 shared B. Weinhold· 1 shared E. Kats· 1 shared H. Tezval· 1 shared

Activity by Year

2022-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCell Biology

C. Rossdam

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Targeting the glycan epitope type I N-acetyllactosamine enables immunodepletion of human pluripotent stem cells from early differentiated cells

C. Rossdam, S. Brand, J. Beimdiek, A. Oberbeck, M. D. Albers, O. Naujok, F. F. R. Buettner

The paper identifies T1LN as a glycan epitope specific to human pluripotent stem cells (hPSCs) that is rapidly downregulated during differentiation, enabling its use for immunodepletion of hPSCs from differentiated cell populations.

bioRxiv · Aug 30, 2023Cell Biology

Neolactotetraosylceramide: A novel non-invasive urinary biomarker for bladder cancer

I. B. Moreira, C. Rossdam, J. Beimdiek, M. M. Vicente, J. Schmitz, A. Oberbeck, J. H. Braesen, H. Tezval, F. F. R. Buettner

This paper identifies neolactotetraosylceramide (nLc4) as a non-invasive urinary biomarker for bladder cancer, showing higher levels in cancer tissues and urine exosomes with high specificity.

bioRxiv · Aug 8, 2023 · PreprintCancer Biology

The monosialoganglioside GM1a protects trophoblasts, erythrocytes and endothelial cells against complement attack

H. Wedekind, J. Beimdiek, C. Rossdam, E. Kats, V. Wittek, L. Schumann, A. Tiede, F. F. R. Buettner, B. Weinhold, A. Muenster-Kuehnel, M. Abeln

This study identifies GM1a as a complement regulator that protects trophoblasts, erythrocytes, and endothelial cells from complement attack through factor H recruitment.

bioRxiv · Jan 24, 2022Biochemistry